Synthetic Biology: At the Crossroads of Genetic Engineering and Human Therapeutics | EK41
Short Talk: Engineered T Cells Directed at Tumors with Defined Allelic Loss
May 4, 2021 11:40am ‐ May 4, 2021 11:55am
, PhD, A2 Biotherapeutics, Inc.
You must be logged in and own this session in order to post comments.
© 2021 Keystone Symposia & Digitell, Inc. All Rights Reserved